(Q52832954)

8 May 2018

title

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies (English)

1 reference

8 May 2018

0 references

0 references

1 reference

Matsuda T

1

1 reference

8 May 2018

Hirano T

series ordinal

2

1 reference

8 May 2018

Kishimoto T

series ordinal

3

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 June 1988

1 reference

8 May 2018

European Journal of Immunology

published in

1 reference

8 May 2018

volume

18

1 reference

8 May 2018

issue

6

1 reference

8 May 2018

page(s)

951-956

1 reference

8 May 2018

describes a project that uses

MH60.BSF2

0 references

cites work

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Molecular regulation of B lymphocyte response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Absence of antiviral activity in recombinant B cell stimulatory factor 2 (BSF-2)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180618

7 January 2021

Identifiers

DOI

10.1002/EJI.1830180618

1 reference

8 May 2018

1 reference

8 May 2018